As discussed above, most hematological malignancies manifest elevated levels of constitutively activated STAT3 and enhanced downstream transcriptional profiles in accordance with STAT3 regulated genes [13,14,71,72]. This evidence concerns the gene STAT3 and hematologic disorder.